Xenon Pharmaceuticals Overview
Xenon Pharmaceuticals Target Price
Analysts' 12-month price predictions for XENE.
Get informed when a big investor buys or sells
+ FollowShare Price
$60.96
Average Target Price
$85.50
40.3% upside
40.3% upside10 analysts in the last 4 months
High: $100 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-10 | Wells FargoBenjamin Burnett | $69 | 13.2% upside |  |
| 2026-05-08 | NeedhamSerge Belanger | $78 | 28% upside | |
| 2026-03-10 | Deutsche Bank | $90 | 47.6% upside | |
| 2026-03-09 | RBC Capital | $80 | 31.2% upside | |
| 2026-03-09 | JefferiesAndrew Tsai | $100 | 64% upside | |
| 2026-03-09 | GuggenheimYatin Suneja | $90 | 47.6% upside | |
| 2026-03-09 | Morgan Stanley | $97 | 59.1% upside | |
| 2026-03-09 | Robert W. Baird | $97 | 59.1% upside | |
| 2026-03-09 | Stifel NicolausPaul Matteis | $89 | 46% upside | |
| 2026-03-09 | JefferiesAndrew Tsai | $65 | 6.6% upside | |
| 2026-02-23 | Wolfe Research | $60 |  1.6% downside | |
| 2026-02-10 | Stifel Nicolaus | $66 | 8.3% upside | |
| 2025-11-04 | RBC Capital | $58 | 4.9% downside | |
| 2025-11-04 | Cantor FitzgeraldJosh Schimmer | $55 | 9.8% downside | |
| 2025-11-04 | Wells FargoBenjamin Burnett | $44 | 27.8% downside | |
| 2025-02-28 | Wedbush | $42 | 31.1% downside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $50 | 18% downside | |
| 2024-10-01 | H.C. WainwrightDouglas Tsao | $53 | 13.1% downside | |
| 2024-08-09 | WedbushLaura Chico | $49 | 19.6% downside | |
| 2024-06-18 | RBC CapitalBrian Abrahams | $55 | 9.8% downside | |
| 2022-12-14 | Goldman Sachs | $60 | 1.6% downside | |
| 2022-11-28 | Wells Fargo | $50 | 18% downside | |
| 2022-11-11 | Guggenheim | $49 | 19.6% downside | |
| 2022-10-18 | Raymond JamesDanielle Brill | $52 | 14.7% downside | |
| 2022-08-11 | Leerink Partners | $46 | 24.5% downside | |
| 2022-08-10 | RBC Capital | $46 | 24.5% downside | |
| 2022-06-27 | Wedbush | $41 | 32.7% downside | |
| 2022-05-11 | RBC Capital | $41 | 32.7% downside | |